Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Outcome Of Board Meeting And Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015

 Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., November 14, 2022, inter alia, considered and approved as per the attached PDF. Further, please find enclosed 'Unaudited Standalone and Consolidated Financial Results along with Limited Review Report, Statement of Assets and Liabilities and Cash Flow Statement' for the quarter and half year ended on September 30, 2022 as Annexure 1, the details required under SEBl (Listing obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD/4/2015 dated 9th September, 2015 is provided as Annexure 2 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 03:30 PM and concluded at 05:25 PM.
14-11-2022
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve With reference to the captioned subject, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, 14th November, 2022 at the registered office of the Company situated at 1-5th Floor, Aditraj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad, Gujarat - 380015, to inter alia consider, approve and take on record the unaudited Financial Results (Standalone and Consolidated) along with Statement of Assets and Liabilities and Cash Flow Statement for quarter and half year ended 30th September, 2022 and any other business items as per agenda circulated.
07-11-2022
Bigul

Medico Intercontinental Ltd - 539938 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Dilipkumar Shah & PACs
11-10-2022
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 11th October, 2022 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of allotment of Equity Shares through preferential issue of Medico Intercontinental Limited on 10th October, 2022. Accordingly, we are enclosing herewith copy of the above disclosure.
11-10-2022
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(3) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 11th October, 2022 under Regulation 7(3) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Siddharth Dinesh Shah, Other connected person of the Company, in respect of allotment of Equity Shares through preferential issue of Medico Intercontinental Limited on 10th October, 2022. Accordingly, we are enclosing herewith copy of the above disclosure.
11-10-2022
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(3) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 11th October, 2022 under Regulation 7(3) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Punit Narendrabhai Shah, Other connected person of the Company, in respect of allotment of Equity Shares through preferential issue of Medico Intercontinental Limited on 10th October, 2022. Accordingly, we are enclosing herewith copy of the above disclosure.
11-10-2022
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(3) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 11th October, 2022 under Regulation 7(3) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Kunal Narendrabhai Shah, Other connected person of the Company, in respect of allotment of Equity Shares through preferential issue of Medico Intercontinental Limited on 10th October, 2022. Accordingly, we are enclosing herewith copy of the above disclosure.
11-10-2022
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(3) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 11th October, 2022 under Regulation 7(3) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Dineshkumar Sevantilal Shah, Other connected person of the Company, in respect of allotment of Equity Shares through preferential issue of Medico Intercontinental Limited on 10th October, 2022. Accordingly, we are enclosing herewith copy of the above disclosure.
11-10-2022
Bigul

Medico Intercontinental Ltd - 539938 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Dinesh Shah & PACs
11-10-2022
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 11th October, 2022 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Dilipkumar Bhogilal Shah, Promoter and CEO of the Company, in respect of allotment of Equity Shares through preferential issue of Medico Intercontinental Limited on 10th October, 2022. Accordingly, we are enclosing herewith copy of the above disclosure.
11-10-2022
Next Page
Close

Let's Open Free Demat Account